CDT Equity (CDT) Metrics: History & Chart

CDT Equity Inc.(CDT)

Biotechnology · Naples, FL

$0.89-0.03 (-3.04%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About CDT Equity Inc.

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Naples, FL

4 employees

www.cdtequity.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jamie Bligh

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	0.00%
30D Total Return	-90.00%
YTD Total Return	-99.90%
1Y Total Return	-99.98%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	N/A
2025	-99.84%
2024	-98.49%
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	N/A
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

CDT Valuation Metrics

CDT Stock Price Metrics

CDT Dividend Metrics

CDT Growth Rate Metrics

CDT Discounted Cash Flow Metrics

CDT Returns By Period

CDT Yearly Returns

CDT Average Annual Returns By Period (CAGR)

CDT Revenue Metrics

CDT PE Ratio Metrics

CDT PS Ratio Metrics

CDT PB Ratio Metrics

CDT Price to Free Cash Flow Ratio Metrics

CDT Debt to Equity Ratio Metrics

CDT PEG Ratio Metrics

CDT FCF Yield

CDT Earnings Yield

CDT EBITDA Yield

CDT OCF Yield

CDT EV/EBIT Ratio Metrics

CDT EV/EBITDA Ratio Metrics

CDT EV/Assets Ratio Metrics

CDT EV/Sales Ratio Metrics

CDT Current Ratio Metrics

CDT Quick Ratio Metrics

CDT ROIC Metrics

CDT Return on Assets Metrics

CDT Return on Equity Metrics

CDT Net Profit Margin Metrics

CDT Gross Profit Margin Metrics

CDT Tax Rate Metrics

PS Ratio	0.00
PS Ratio Avg TTM	0.02
PS Ratio Avg 3Y	0.02
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PB Ratio	0.00
PB Ratio Avg TTM	2.06
PB Ratio Avg 3Y	3.92
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PFCF Ratio	0.17
PFCF Ratio Avg TTM	0.46
PFCF Ratio Avg 3Y	0.46
Current VS TTM Avg	-63.41%
Current VS 3Y Avg	-63.41%
Current VS 5Y Avg	-63.41%

Debt/Equity Ratio	0.95
Debt/Equity Ratio Avg TTM	0.87
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	+10.14%
Current VS 3Y Avg	+22951.82%
Current VS 5Y Avg	+699.06%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	602.59%
FCF Yield Avg TTM	270.54%
FCF Yield Avg 3Y	270.54%
Current VS TTM Avg	+122.73%
Current VS 3Y Avg	+122.73%
Current VS 5Y Avg	+122.73%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	5.81
Ev/Ebit Ratio Avg TTM	18.06
Ev/Ebit Ratio Avg 3Y	18.06
Current VS TTM Avg	-67.83%
Current VS 3Y Avg	-67.83%
Current VS 5Y Avg	-67.83%

Ev/Ebitda Ratio	4.13
Ev/Ebitda Ratio Avg TTM	10.27
Ev/Ebitda Ratio Avg 3Y	9.51
Current VS TTM Avg	-59.77%
Current VS 3Y Avg	-56.59%
Current VS 5Y Avg	-56.59%

Ev/Assets Ratio	0.28
Ev/Assets Ratio Avg TTM	0.97
Ev/Assets Ratio Avg 3Y	25.69
Current VS TTM Avg	-70.99%
Current VS 3Y Avg	-98.91%
Current VS 5Y Avg	-98.91%

Ev/Sales Ratio	0.67
Ev/Sales Ratio Avg TTM	1.27
Ev/Sales Ratio Avg 3Y	1.27
Current VS TTM Avg	-47.09%
Current VS 3Y Avg	-47.09%
Current VS 5Y Avg	-47.09%

Current Ratio	2.14
Current Ratio Avg TTM	1.95
Current Ratio Avg 3Y	1.51
Current VS TTM Avg	+9.23%
Current VS 3Y Avg	+41.60%
Current VS 5Y Avg	+52.38%

Quick Ratio	1.49
Quick Ratio Avg TTM	1.48
Quick Ratio Avg 3Y	1.47
Current VS TTM Avg	+0.94%
Current VS 3Y Avg	+1.50%
Current VS 5Y Avg	+9.77%

ROIC	4.47%
ROIC Avg 3Y	(313.38%)
ROIC Avg 5Y	(100.87%)
Current VS 3Y Avg	+101.43%
Current VS 5Y Avg	+104.43%
Current VS 10Y Avg	+104.43%

ROA	2.60%
ROA Avg TTM	(20.10%)
ROA Avg 3Y	(39.51%)
Current VS TTM Avg	+112.93%
Current VS 3Y Avg	+106.58%
Current VS 5Y Avg	+109.13%

ROE	6.58%
ROE Avg TTM	(117.47%)
ROE Avg 3Y	(253.92%)
Current VS TTM Avg	+105.60%
Current VS 3Y Avg	+102.59%
Current VS 5Y Avg	+103.27%

Net Profit Margin	6.30%
Net Profit Margin Avg TTM	4.12%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	+53.06%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	19.30%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	19.56%
Tax Rate Avg 3Y	9.57%
Tax Rate Avg 5Y	9.57%
Current VS 3Y Avg	+104.46%
Current VS 5Y Avg	+104.46%
Current VS 10Y Avg	+104.46%